Evercore ISI lifts CRISPR stock rating, target
Evercore ISI has upgraded CRISPR (CRSP) to outperform from in line, citing upcoming data catalysts. Read more here.
Evercore ISI analyst Kirk Materne maintained a Hold rating on Tyler Technologies (TYL – Research Report) yesterday and set a price target of ...
Walgreens Chief Executive Officer Tim Wentworth reiterated on an earnings call last month that the company plans to divest ...
Zillow Group (NASDAQ:ZG – Get Free Report) had its target price boosted by equities research analysts at Evercore ISI from $75.00 to $90.00 in a research report issued on Wednesday,Benzinga reports.
Evercore ISI analyst David Palmer maintained a Buy rating on Restaurant Brands International (QSR – Research Report) yesterday and set a price ...
James Yaro; Analyst; Goldman Sachs & Company, Inc. Brendan O’Brien; Analyst; Wolfe Research Aidan Hall; Analyst; Keefe, Bruyette & Woods, Inc. Good morning and welcome to the Evercore fourth ...
(EVR) on Wednesday reported net income of $140.4 million in its fourth quarter. The company, based in New York, said it had earnings of $3.30 per share.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results